Financials

  • Market Capitalization 3.9 B
  • Employee 601
  • Founded 2015
  • CEO -
  • Website www.arcusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00DQD26W3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.24
Rapporto prezzo/fatturato
10.36

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1522
VKTX
Viking Therapeutics, Inc. - Common Stock
33.86 USD-1.51%-2.67%+0.03%+22.42%3.95 B USD
1523
DNLI
Denali Therapeutics Inc. - Common Stock
24.67 USD+0.41%-2.26%+3.31%+52.57%3.94 B USD
1545
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.38 USD+2.25%+0.35%+10.70%+80.35%3.86 B USD
1557
ABCL
AbCellera Biologics Inc. - Common Shares
11.91 USD-3.95%+3.93%+121.38%+176.98%3.65 B USD

Notizie